Karanjin, A Promising Bioactive Compound Possessing Anti-cancer Activity against Experimental Model of Non-small Cell Lung Cancer Cells

Author:

Kumar Gourav123,Pandey Dev Mani1,Ghosh Manik4,Dall'Acqua Stefano3,Gupta Rashmi13,Tiwari Nishi Prakash1,Mohd Siddique Usman4,Vishwakarma Leena2,Guleri Sunil Kant2,Lal Uma Ranjan45,Dubey Supriya6

Affiliation:

1. Department of Bioengineering and Biotechnology, Birla Institute of Technology, Mesra, Ranchi, India

2. Birsa Munda Government Medical College, Shahdol, India

3. Department of Pharmaceutical and Pharmacological Science, University of Padova, Italy

4. Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India

5. Department of Natural Products, NIPER Ahmedabad, India

6. Department of Chemistry, Kanya Gurukul Campus, Gurukul Kangri (Deemed to be University), Haridwar, India

Abstract

Aims:: The aim of this study is to isolate the Millettia pinnata (Karanj) leaf extract for pure compound with anticancer properties and to study the molecular target of the isolates in non-small cell lung cancer cell lines. background: In our earlier research Millettia pinnata leaf extract has demonstrated potential anticancer activities. Thus, in pursuit of the bioactive compound most potential active extract from our previous study was purified. Furthermore, anticancer properties of the isolated compound karanjin was studied and aimed, inducing apoptosis and restraining growth objective: The objective of this study was to identify the key molecules involved in restrain cancer proliferation, by inducing apoptosis, Isolation and characterization of the molecule and identify the molecular mechanism of action. method: A novel method was developed through column chromatography for isolation and purification of the compound karanjin from leaf chloroform extract. The purified component was then characterised using mass spectrometry, FTIR, and NMR. An MTT-based cytotoxicity assay was used to analyse cell cytotoxicity, whereas fluorescence staining were used for apoptosis and reactive oxygen species inhibition quantification. Furthermore the real-time PCR assay was used to determine the molecular mechanism of action in cells causing cytotoxicity induced by karanjin dosing. result: The anticancer activity of karanjin in A549 cell line exhibited prominent activity revealing IC50 value of 4.85 µM. Conferring the predicted molecular pathway study, karanjin restrains the proliferation of cancer cells through apoptosis, which is controlled by extrinsic pathway enzymes FAS/FADD/Caspases 8/3/9. Down-regulation of KRAS and dependent gene expression also stopped cell proliferation. conclusion: Karanjin has been identified as compound with potential effect in non-small cell lung cancer. Molecular mechanism for apoptosis and inhibition of reactive oxygen species induced through H2O2 were observed concluding karanjin having medicinal and antioxidant properties.

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Pharmacology,Molecular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3